Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1

Yun Kenneth Kang1, Sofija Andjelic, James M Binley

  • 1Progenics Pharmaceuticals, Inc., Tarrytown, NY 10591, United States. kkang@progenics.com

Vaccine
|July 2, 2009
PubMed